Zauner W
Forschungsabteilung, Novo Nordisk Pharma GesmbH, Erdbergstrasse 52-60, A-1030 Wien.
Acta Med Austriaca Suppl. 2002;56:4-5.
In Austria in 1999, a Diabetes screening program was carried out by the Austrian Diabetes Association and by Novo Nordisk and Roche Diagnostics with a special equipped bus touring through more than 90 cities. The population was invited to a screening of blood glucose (random), blood pressure, body weight und serum-cholesterol. The diabetes risk was evaluated by history and familiar burden with a questionnaire. The results were handed over to the visitors and their general practitioners, and a copy was used for anonymously analysis.
1999年在奥地利,奥地利糖尿病协会、诺和诺德公司以及罗氏诊断公司开展了一项糖尿病筛查项目,一辆经过特殊装备的巴士穿梭于90多个城市。民众被邀请参加血糖(随机)、血压、体重和血清胆固醇的筛查。通过问卷调查了解病史和家族病史来评估糖尿病风险。结果会交给受检者及其全科医生,其中一份副本用于匿名分析。